Cardiologists are scrambling to explain why the negative results of a big and important new clinical trial of a lucrative, frequently performed procedure should not change the way they treat patients.
Cardiologists are scrambling to explain why the negative results of a big and important new clinical trial of a lucrative, frequently performed procedure should not change the way they treat patients.